Skip to content

API Data Insights

Numbers don’t lie, companies do

  • All News
  • Deep Dives
  • Signals
  • Case Files
  • Opinion
  • Exposés
  • Regulatory

Newswire

STAT+ Reveals EPIC Investigation and Unanticipated Developments from Teladoc
Newswire

STAT+ Reveals EPIC Investigation and Unanticipated Developments from Teladoc

October 31, 2026
STAT has announced its participation in the HLTH conference in Las Vegas on November 18,…
ICH Adopts New M15 Guideline for Model-Informed Drug Development
Newswire

ICH Adopts New M15 Guideline for Model-Informed Drug Development

October 31, 2026
Adopted by the International Council for Harmonisation (ICH) in February 2026, the new ICH M15…
Genmab Soars to Record Highs After Cancer Drug Succeeds in Key Trial
Newswire

Genmab Soars to Record Highs After Cancer Drug Succeeds in Key Trial

October 31, 2026
Genmab’s market capitalization surged by over $7 billion following positive trial results for a recently-acquired…
RFK Jr backs compounding of six unapproved peptides in new policy
Newswire

RFK Jr backs compounding of six unapproved peptides in new policy

October 31, 2026
In a significant move for the pharmaceutical compounding sector, Robert F. Kennedy Jr. has endorsed…
Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply
Newswire

Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply

October 31, 2026
Gaelic Labs anticipates significant advantages stemming from the EU’s Critical Medicines Act, which aims to…
HHS to Allow Compounders to Make 6 Unapproved Peptides
Newswire

HHS to Allow Compounders to Make 6 Unapproved Peptides

October 31, 2026
The U.S. Department of Health and Human Services (HHS) has announced that it will not…
IDWeek 2026: Abrysvo Data in Nursing Home Residents Could Support Re-vaccination
Newswire

IDWeek 2026: Abrysvo Data in Nursing Home Residents Could Support Re-vaccination

October 31, 2026
Abrysvo, a respiratory syncytial virus (RSV) vaccine, was first approved in the United States in…
FDA Issues Guidance on Essential Drug Delivery Performance Characteristics for Devices
Newswire

FDA Issues Guidance on Essential Drug Delivery Performance Characteristics for Devices

October 31, 2026
The FDA has released new guidance aimed at enhancing the development of stand-alone devices and…
Kennedy’s Rally Highlights Growing Opposition to Vaccines and Big Agriculture Ahead of 2026 Midterms
Newswire

Kennedy’s Rally Highlights Growing Opposition to Vaccines and Big Agriculture Ahead of 2026 Midterms

October 30, 2026
On Wednesday night in Clive, Iowa, a gathering of Make America Healthy Again activists and…
AAV Gene Therapies Demand New Strategies for Sustainable Development
Newswire

AAV Gene Therapies Demand New Strategies for Sustainable Development

October 30, 2026
Adeno-associated virus (AAV) gene therapies have transformed the treatment landscape for rare and genetic diseases,…

About Us

For years we’ve built comprehensive pharmaceutical databases, collecting API, FDF, and excipient suppliers worldwide, with pricing and regulatory details.

Now we present this journal & store: coverage of pharma events, news, and market trends.

Read more →

Contact & Support

Company: API DATA

Location: Israel, Northern District — Gidona

Email: support@api-fdf.com

Connect

Explore our API & FDF Intelligence Database for structured insights on APIs, FDFs, excipients, and compliance worldwide.

Follow updates on LinkedIn.

  • Privacy Policy
  • About Us
  • Home
© API DATA, 2025. All rights reserved Theme: Eternal News By Artify Themes.